If the sinful excess of holiday eating sends your system into overload, you may be upsetting the body’s “food clock,” which keeps the human body on a metabolic even keel. A new study by UCSF researchers is helping to reveal how this clock works on a molecular level.
December 21, 2012
November 19, 2012
DNA sequences obtained from a handful of patients with multiple sclerosis at the UCSF Medical Center have revealed the existence of an “immune exchange” that allows the disease-causing cells to move in and out of the brain.
October 19, 2012
As part of receiving the Academic Senate's 12th Annual Faculty Research Lectureship in Clinical Science, behavioral neurologist Bruce Miller, MD, recently gave a lecture in which he described recent advances in frontotemporal dementia (FTD) research.
October 11, 2012
The unexpected survival of embryonic neurons transplanted into the brains of newborn mice in a series of experiments at the University of California, San Francisco (UCSF) raises hope for the possibility of using neuronal transplantation to treat diseases like Alzheimer’s, epilepsy, Huntington’s, Parkinson’s and schizophrenia.
October 10, 2012
A new study that represents a significant first step in exploring the potential of stem cells to treat neurological disease is a “natural outgrowth” of a longstanding culture of interdisciplinary collaboration in UCSF neonatology — a culture that UCSF Benioff Children's Hospital physicians David Rowitch and Donna Ferriero work hard to sustain.
September 20, 2012
Bruce L. Miller, MD, professor of neurology and psychiatry at UCSF where he holds the A.W. & Mary Margaret Clausen Distinguished Chair, is the recipient of the 12th Annual Faculty Research Lectureship in Clinical Science for his legacy-building work on frontotemporal dementia and related disorders, including Alzheimer’s disease.
August 08, 2012
There is no cure for multiple sclerosis, but several medications can help slow its devastating effects, and extend healthier years for the roughly 2.5 million people worldwide diagnosed with this chronic neurological disease.
August 06, 2012
Scientists at the UCSF-affiliated Gladstone Institutes have discovered that an FDA-approved anti-epileptic drug reverses memory loss and alleviates other Alzheimer’s-related impairments in an animal model of the disease.
June 07, 2012
Scientists at the Gladstone Institutes have for the first time transformed skin cells — with a single genetic factor — into cells that develop on their own into an interconnected, functional network of brain cells.
May 24, 2012
UCSF has received a challenge gift of $20 million from the Sandler Foundation that will provide major support for the university’s groundbreaking research and clinical care efforts regarding neurological diseases.